Mukka Proteins IPO Review: Should You Apply Before Bidding Ends Today?

by

With the Mukka Proteins IPO bidding ending today, investors are eager to know whether they should apply for the public issue or not. In this article, we will review the IPO’s Grey Market Premium (GMP), subscription status, and expert recommendations to help you make an informed decision.

Contents hide
1 Mukka Proteins IPO Overview:
2 Expert Recommendations:
3 FAQs:
4 Conclusion: To Apply or Not?

Mukka Proteins IPO Overview: 

Mukka Proteins Limited, a fish protein products maker, has launched its IPO with a price band of ₹26 to ₹28 per equity share. The company aims to raise ₹224 crore through the issuance of fresh shares. The IPO has received a positive response from anchor investors and primary market investors, with the book build issue being subscribed 6.97 times in the first two days of bidding.

Grey Market Premium and Subscription Status: The Grey Market Premium (GMP) for Mukka Proteins IPO is currently at ₹30, indicating strong demand and bullish sentiment among investors. The subscription status shows that the IPO has been oversubscribed, with Retail and Non-Institutional Investors Portions being subscribed 10.20 times and 6.22 times, respectively. Qualified Institutional Buyers have subscribed 1.86 times.

Expert Recommendations: 

Analysts from BP Equities and Kejriwal Research and Investment Services have given a “subscribe” and “buy” rating respectively for the IPO. They highlight the company’s strong market position, consistent financial performance, and attractive valuations as reasons to invest in Mukka Proteins Limited.

FAQs:

  1. What is the price band for Mukka Proteins IPO?
    • The price band for Mukka Proteins IPO is set at ₹26 to ₹28 per equity share.
  2. How many times has the IPO been subscribed so far?
    • The IPO has been subscribed 6.97 times in the first two days of bidding.
  3. What is the Grey Market Premium (GMP) for Mukka Proteins IPO?
    • The GMP for Mukka Proteins IPO is currently at ₹30.
  4. What do expert analysts recommend regarding the IPO?
    • Analysts recommend subscribing to or buying shares of Mukka Proteins Limited for potential listing gains.
  5. When does the bidding for Mukka Proteins IPO end?
    • The bidding for Mukka Proteins IPO ends today, March 4, 2024.

Conclusion: To Apply or Not? 

Considering the positive subscription status, strong Grey Market Premium, and expert recommendations, investors may find Mukka Proteins IPO a promising investment opportunity. It is advisable to consult with certified experts and conduct thorough research before making any investment decisions. Apply for the IPO before bidding ends today to potentially benefit from listing gains in the future.

Leave a Comment